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THE EFFECTS OF THE NOREPINEPHRINE AGONIST, GUANFACINE, ON 
SCOPOLAMlNE·INDUCED MEMORY IMPAIRMENTS IN THE RAT 
Andrew Tharp and Renee Countryman* 
Psychology Department, Illinois Wesleyan University 
Cognitive deficits associated with Alzheimer's disease are known to result from decreases in 
acetylcholine within the cholinergic system of the medial septal area, which projects to the 
hippocampus. Recent studies suggest that increasing · levels of the neurotransmitter 
norepinephrine may help to decrease the cognitive impairments associated with Alzheimer's 
disease and aging. The present study measured the effects that Guanfacine, an alpha-2 
noradrenergic agonist, has on memory deficits produced by the acetylcholine antagonist, 
Scopolamine. Memory ability was assessed using an object recognition task and a socially 
transmitted food preference task. Following administration of Scopolamine, memory ability was 
significantly impaired from baseline levels on both memory tasks. Pre-training injection of 
Scopolamine followed by post-training injection of Guanfacine resulted in memory performance 
that was equivalent to baseline memory performance on both tasks. Guanfacine administration 
alone did not improve memory performance, but rather had a trend toward impairing 
performance. Results from this study indicate that Guanfacine may be effective at improving 
memory impairments caused by decreased acetylcholine function as seen in Alzheimer's  disease. 
